Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer

British Journal of Cancer

Volumn 91, Issue 6, 2004, Pages 1032-1037

  Tsuda, H ^a,b   Hashiguchi, Y ^a,b   Nishimura, S ^a   Miyama, M ^a   Nakata, S ^a   Kawamura, N ^a   Negoro, S ^b  

^a Department of Obstetrics ^*  (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Adenocarcinoma of uterine cervix; Cervical cancer; Combination chemotherapy; Phase I study; Phase II study

Indexed keywords

IRINOTECAN; NEDAPLATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; ASCITES; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; FEMALE; HEMATURIA; HUMAN; INTERSTITIAL PNEUMONIA; INTESTINE OBSTRUCTION; LETHARGY; LEUKOPENIA; LIVER TOXICITY; LUNG FIBROSIS; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SURVIVAL TIME; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RECURRENCE; UTERINE CERVICAL NEOPLASMS;

EID: 5044230644     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602076     Document Type: Article

References (32)

1. Bonomi P, Blessing JA, Stehman FB (1985) Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 3: 1079-1085
2. Brader KR, Morris M, Levenback C, Levy L, Lucas KR, Gershenson DM (1998) Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16: 1879-1884
3. Buxton EJ, Meanwell CA, Hilton C, Mould JJ, Spooner D, Chetiyawardana A, Latief T, Paterson M, Redman CW, Luesley DM (1989) Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 81: 359-361
4. Ivrin WP, Price FV, Bailey H, Gelder M, Rosenbluth R, Durivage HJ, Potkul RK (1998) A phase II study of irinotecan (CPT-11) for patients with advanced squamous cell carcinoma of the cervix. Cancer 82: 328-333
5. Kameyama Y, Okazaki N, Nakagawa M, Koshida H, Nakamura M, Gemba M (1990) Nephrotoxicity of a new platinum compound, evaluated with rat kidney cortical slices. Toxicol Lett 52: 15-24
6. Kanazawa F, Koizumi F, Koh Y, Nakamura T, Tatsumi Y, Fukumoto H, Saijo N, Yoshida T, Nishio K (2001) In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction. Clin Cancer Res 7: 202-209
7. Kato T, Nishimura H, Yakushiji M, Noda K, Terashima Y, Takeuchi S (1992) Phase II study of 254-S for gynecological cancer. Jpn J Cancer Chemother 19: 695-701
8. Long III HJ, Cross WG, Wieand HS, Webb MJ, Mailliard JA, Kugler JW, Tschetter LK, Kardinal CG, Ebbert LP, Rayson S (1995) Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina. Gynecol Oncol 57: 235-239
9. Machida S, Ohwada M, Fujiwara H, Konno R, Takano M, Kita T, Kikuchi Y, Komiyama S, Mikami M, Suzuki M (2003) Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer. Oncology 65: 102-107
10. McGuire WP, Blessing JA, Moore D, Lentz SS, Photopulos G (1996) Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group Study. J Clin Oncol 14: 792-795
11. Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, Gershenson DM (1998) Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol 16: 1094-1098
12. Murad AM, Triginelli SA, Ribalta JC (1994) Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer. J Clin Oncol 12: 55-59
13. Nitta K, Yokokura T, Sawada S, Kunimoto T, Tanaka T, Uehara N, Baba H, Takeuchi M, Miyasaka S, Mudai H (1987) Antitumor activity of novel derivatives of camptothecin. Gan To kagaku Ryoho 14: 850-857
14. Omura GA, Blessing JA, Vaccarello L, Berman ML, Clarke-Pearson DL, Mutch DG, Anderson B (1997) Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 15: 165-171
15. Oshita F, Yamada K, Kato Y, Ikehara M, Noda K, Tanaka G, Nomura I, Suzuki R, Saito H (2003) Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 52: 73-78
16. Ota K, Oguma T, Shimamura K (1994) Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine (glycolato) platinum, 254-S. Anticancer Res 14: 1383-1388
17. Ota K, Wakui A, Mashima N, Niitani H, Inuyama M, Ogawa I, Ariyoshi H, Yoshida O, Taguchi T, Kimura I, Katoh S (1992) Phase II study of a new platinum complex 254-S, cis-diammine (glycolato) platinum(II). Jpn J Cancer Chemother 19: 855-861, (in Japanese)
18. Papadimitriou CA, Dimopoulos MA, Giannakoulis N, Sarris K, Vassilakopoulos G, Akrivos T, Voulgaris Z, Vlahos G, Diakomanolis E, Michalas S (1997) A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix. Cancer 79: 2391-2395
19. Papadimitriou CA, Sarris K, Moulopoulos LA, Fountzilas G, Anagnostopoulos A, Voulgaris Z, Gika D, Giannakoulis N, Diakomanolis E, Dimopoulos MA (1999) Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 17: 761-766
20. Robert TG, Mary BH, Taylor M, Michael T (2001) Cancer statistics 2001. CA Cancer J Clin 51: 15-36
21. Rose PG, Blessing JA, Gershenson DM, McGehee R (1999) Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 17: 2676-2680
22. Sasaki Y, Tamura T, Eguchi K, Shinkai T, Fujiwara Y, Fukuda M, Ohe Y, Bungo M, Horichi N, Niimi S, Minato K, Nakagawa K, Saijo N (1989) Pharmacokinetics of (glycolato-O,O′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin. Cancer Chemother Pharmacol 23: 243-246
23. Sekiya M (2002) Reports of the gynecologic tumor committee. Acta Obstet Gynaecol Jpn 54: 697-793, (in Japanese)
24. Sugeno K, Mizojiri K, Okabe H, Esumi Y, Takaichi M, Okada Y (1991) Study on the disposition of a new antineoplastic agent, cis-diammine (glycolate) platinum(254-S). Iyakuhin Kenkyu 22: 231-242
25. Suzumura Y, Kato T, Ueda R, Ota K (1989) Effect of treatment schedule on antitumor activity of glycolato-O,O′-diammine platinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II). Anticancer Res 9: 1083-1088
26. Takeuchi S, Dobashi K, Fujimoto S, Tanaka K, Suzuki M, Terashima Y, Hasumi K, Akiya K, Negishi Y, Tamamaya T, Tanizawa O, Sugawa T, Umesaki N, Sekiba T, Aono T, Nakano H, Noda K, Shiota M, Yakushiji M, Sugiyama T, Hashimoto M, Yamaji A, Takamizawa H, Sonoda T, Takeda Y, Tomoda Y, Ohta M, Ozaki M, Hirabayashi K, Hiura M, Hatae M, Nishigaki K, Taguchi T (1991) A late phase II study of CPT-11 for uterine cervical cancer and ovarian cancer. Gan To kagaku Ryoho 18: 1681-1689
27. Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J (1981) Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Phase II study of the Gynecologic Oncology Group. Cancer 48: 899-903
28. Thigpen T, Vance R, Khansur T (1994) Carcinoma of the uterine cervix: current status and future directions. Semin Oncol 21: 43-56
29. Thigpen T, Vance RB, Khansur T (1995) The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Semin Oncol 22, (Suppl 12) 67-75
30. Tobina K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K, Narabayashi M, Fukutomi T, Kondo H, Shimoyama M, Suemasu K, members of the Clinical Trial Review Committee of the Japan Clinical Oncology Group (1993) Toxicity grading criteria of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23: 250-257
31. Verschraegen CF, Levy T, Kudelka AP, Lierena E, Freedman RS, Edwards CL, Hord M, Steger M, Kaplan AL, Kieback D, Fishman A, Kavanagh JJ (1997) Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. J Clin Oncol 15: 625-631
32. World Health Organization (1979) Handbook for Reporting Results of Cancer Treatment, Offset publication no. 48. Geneva: World Health Organization